Scott Kellen
CFO & Secretary at DiaMedica Therapeutics Inc. (DMAC)
Scott Kellen has filed 8 insider reports with the SEC since July 2021, as CFO & Secretary at DiaMedica Therapeutics Inc. (DMAC). Scott Kellen made no open-market purchases or sales in the last 12 months. The latest filing, on June 3, 2026, reports grant or award at DiaMedica Therapeutics Inc. (DMAC).
- Filings
- 8
- Companies
- 1
- Bought on market
- $70.6K
- Sold on market
- None
Companies where Scott Kellen is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| CFO & Secretary | 32,290 | $70.6K | $3.53 | $8.25+134% | Jun 3, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jun 1, 2026DMACSEC Form 4 filed by CFO & Secretary Kellen ScottForm 4Grant or award
- Jun 1, 2025DMACSEC Form 4 filed by CFO & Secretary Kellen ScottForm 4Grant or award
- Jun 1, 2024DMACSEC Form 4 filed by Kellen ScottForm 4Grant or award
- Jun 23, 2023+$39.1KDMACSEC Form 4 filed by Kellen ScottForm 4Open-market purchase
- Jun 1, 2023DMACSEC Form 4 filed by Kellen ScottForm 4Grant or award
- Jun 1, 2022DMACSEC Form 4 filed by Kellen ScottForm 4Grant or award
- Aug 16, 2021+$31.5KDMACSEC Form 4: Kellen Scott bought $31,463 worth of Voting Common Shares (10,000 units at $3.15), increasing direct ownership by 81% to 22,290 unitsForm 4Open-market purchase
- Jul 28, 2021DMACSEC Form 4 filed by Kellen ScottForm 4Grant or award
Compare Scott Kellen with
- Scott Kellen vs Dietrich John Pauls1 shared
- Scott Kellen vs Randall Michael Giuffre1 shared
- Scott Kellen vs Richard Kuntz1 shared
- Scott Kellen vs Daniel J. O'Connor1 shared
- Scott Kellen vs Tanya Lewis1 shared
- Scott Kellen vs Charles Pauling Semba1 shared
Other insiders at the same companies
- Dietrich John PaulsDMAC
- Randall Michael GiuffreDMAC
- Richard KuntzDMAC
- Daniel J. O'ConnorDMAC
- Tanya LewisDMAC
- Charles Pauling SembaDMAC
- James T. ParsonsDMAC
- Julie KropDMAC
- Jan StahlbergDMAC
- Thomas Von KochDMAC
- Richard Jacinto IIDMAC
- David J. WambekeDMAC
- Richard D. PilnikDMAC
Questions about Scott Kellen
- What is Scott Kellen's role at DiaMedica Therapeutics Inc.?
- Scott Kellen reports to the SEC as CFO & Secretary at DiaMedica Therapeutics Inc. (DMAC), according to the latest filing on June 3, 2026.
- How many shares does Scott Kellen own?
- After the latest filing that states it, Scott Kellen directly owned 32,290 shares of DiaMedica Therapeutics Inc. (DMAC). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Scott Kellen bought or sold stock recently?
- The most recent open-market purchase was on June 23, 2023: bought 10,000 shares of DiaMedica Therapeutics Inc. (DMAC) for $39.1K at an average of $3.91.
- How do I get alerts when Scott Kellen files?
- Follow Scott Kellen on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Scott Kellen (SEC CIK 0001490476). Totals count each trade once, skipping amendments whose original is on file, from Jul 30, 2021 on. View on SEC EDGAR · Get this as JSON